Report Detail

Other Global Adoptive Cellular Immunotherapy Market Status and Forecast 2021-2027

  • RnM4335135
  • |
  • 20 July, 2021
  • |
  • Global
  • |
  • 141 Pages
  • |
  • GRD Survey
  • |
  • Other

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Adoptive Cellular Immunotherapy Market Status and Forecast (2016-2027)
      • 1.3.2 Global Adoptive Cellular Immunotherapy Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Adoptive Cellular Immunotherapy Supply by Company

    • 2.1 Global Adoptive Cellular Immunotherapy Sales Value by Company
    • 2.2 Adoptive Cellular Immunotherapy Sales Area of Main Manufacturers
    • 2.3 Trend of Concentration Rate

    3 Global and Regional Adoptive Cellular Immunotherapy Market Status by Type

    • 3.1 Adoptive Cellular Immunotherapy Type Introduction
      • 3.1.1 TIL
      • 3.1.2 LAK
      • 3.1.3 CAR-T
      • 3.1.4 TCR-T
      • 3.1.5 CIK
      • 3.1.6 NK
      • 3.1.7 DC
      • 3.1.8 Other
    • 3.2 Global Adoptive Cellular Immunotherapy Market by Type
    • 3.3 North America: by Type
    • 3.4 Europe: by Type
    • 3.5 Asia Pacific: by Type
    • 3.6 Central & South America: by Type
    • 3.7 Middle East & Africa: by Type

    4 Global and Regional Adoptive Cellular Immunotherapy Market Status by Application

    • 4.1 Adoptive Cellular Immunotherapy Segment by Application
      • 4.1.1 Hospital
      • 4.1.2 Cancer Hospital
      • 4.1.3 Centers for Disease Control and Prevention
      • 4.1.4 Rehabilitation Center
      • 4.1.5 Other
    • 4.2 Global Adoptive Cellular Immunotherapy Market by Application
    • 4.3 North America: by Application
    • 4.4 Europe: by Application
    • 4.5 Asia Pacific: by Application
    • 4.6 Central & South America: by Application
    • 4.7 Middle East & Africa: by Application

    5 Global Adoptive Cellular Immunotherapy Market Status by Region

    • 5.1 Global Adoptive Cellular Immunotherapy Market by Region
    • 5.2 North America Adoptive Cellular Immunotherapy Market Status
    • 5.3 Europe Adoptive Cellular Immunotherapy Market Status
    • 5.4 Asia Pacific Adoptive Cellular Immunotherapy Market Status
    • 5.5 Central & South America Adoptive Cellular Immunotherapy Market Status
    • 5.6 Middle East & Africa Adoptive Cellular Immunotherapy Market Status

    6 North America Adoptive Cellular Immunotherapy Market Status

    • 6.1 North America Adoptive Cellular Immunotherapy Market by Country
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Adoptive Cellular Immunotherapy Market Status

    • 7.1 Europe Adoptive Cellular Immunotherapy Market by Country
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Adoptive Cellular Immunotherapy Market Status

    • 8.1 Asia Pacific Adoptive Cellular Immunotherapy Market by Country
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Adoptive Cellular Immunotherapy Market Status

    • 9.1 Central & South America Adoptive Cellular Immunotherapy Market by Country
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Adoptive Cellular Immunotherapy Market Status

    • 10.1 Middle East & Africa Adoptive Cellular Immunotherapy Market by Country
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Major Downstream Customers Analysis

    • 11.1 Customer One Analysis
    • 11.2 Customer Two Analysis
    • 11.3 Customer Three Analysis
    • 11.4 Customer Four Analysis

    12 Global Adoptive Cellular Immunotherapy Market Forecast by Type and by Application

    • 12.1 Global Adoptive Cellular Immunotherapy Sales Value Forecast (2022-2027)
    • 12.2 Global Adoptive Cellular Immunotherapy Forecast by Type
    • 12.3 Global Adoptive Cellular Immunotherapy Forecast by Application

    13 Global Adoptive Cellular Immunotherapy Market Forecast by Region/Country

    • 13.1 Global Adoptive Cellular Immunotherapy Market Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Takara Bio Inc
      • 14.1.1 Company Information
      • 14.1.2 Adoptive Cellular Immunotherapy Product Introduction
      • 14.1.3 Takara Bio Inc Adoptive Cellular Immunotherapy Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 Sorrento Therapeutics Inc
      • 14.2.1 Company Information
      • 14.2.2 Adoptive Cellular Immunotherapy Product Introduction
      • 14.2.3 Sorrento Therapeutics Inc Adoptive Cellular Immunotherapy Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
      • 14.3.1 Company Information
      • 14.3.2 Adoptive Cellular Immunotherapy Product Introduction
      • 14.3.3 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular Immunotherapy Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 Ono Pharmaceutical Co Ltd
      • 14.4.1 Company Information
      • 14.4.2 Adoptive Cellular Immunotherapy Product Introduction
      • 14.4.3 Ono Pharmaceutical Co Ltd Adoptive Cellular Immunotherapy Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 Novartis AG
      • 14.5.1 Company Information
      • 14.5.2 Adoptive Cellular Immunotherapy Product Introduction
      • 14.5.3 Novartis AG Adoptive Cellular Immunotherapy Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 Nkarta Inc
      • 14.6.1 Company Information
      • 14.6.2 Adoptive Cellular Immunotherapy Product Introduction
      • 14.6.3 Nkarta Inc Adoptive Cellular Immunotherapy Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 NantKwest Inc
      • 14.7.1 Company Information
      • 14.7.2 Adoptive Cellular Immunotherapy Product Introduction
      • 14.7.3 NantKwest Inc Adoptive Cellular Immunotherapy Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 Nanjing Legend Biotech Co Ltd
      • 14.8.1 Company Information
      • 14.8.2 Adoptive Cellular Immunotherapy Product Introduction
      • 14.8.3 Nanjing Legend Biotech Co Ltd Adoptive Cellular Immunotherapy Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.8.4 SWOT Analysis
    • 14.9 Kite Pharma Inc
      • 14.9.1 Company Information
      • 14.9.2 Adoptive Cellular Immunotherapy Product Introduction
      • 14.9.3 Kite Pharma Inc Adoptive Cellular Immunotherapy Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.9.4 SWOT Analysis
    • 14.10 Juno Therapeutics Inc
      • 14.10.1 Company Information
      • 14.10.2 Adoptive Cellular Immunotherapy Product Introduction
      • 14.10.3 Juno Therapeutics Inc Adoptive Cellular Immunotherapy Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.10.4 SWOT Analysis
    • 14.11 HRAIN Biotechnology Co Ltd
    • 14.12 Hebei Senlang Biotechnology Inc Ltd
    • 14.13 Hangzhou Converd Co Ltd
    • 14.14 Guangzhou Anjie Biomedical Technology Co Ltd
    • 14.15 Gilead Sciences Inc
    • 14.16 Fosun Pharmaceutical AG
    • 14.17 Daiichi Sankyo Co Ltd
    • 14.18 Celyad SA
    • 14.19 Celularity Inc
    • 14.20 Cellular Biomedicine Group Inc
    • 14.21 Cell Medica Ltd
    • 14.22 Celgene Corp
    • 14.23 CARsgen Therapeutics Ltd
    • 14.24 Bristol-Myers Squibb Co
    • 14.25 bluebird bio Inc
    • 14.26 Bellicum Pharmaceuticals Inc
    • 14.27 Beijing Immunochina Medical Science & Technology Co Ltd
    • 14.28 Autolus Therapeutics Plc
    • 14.29 Amgen Inc

    15 Conclusion

      16 Methodology

      This report provides a comprehensive analysis of current global Adoptive Cellular Immunotherapy market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario.This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Adoptive Cellular Immunotherapy industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

      According to this survey, the global Adoptive Cellular Immunotherapy market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million by 2027.

      Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Adoptive Cellular Immunotherapy Market Status and Forecast 2021-2027 report makes a brilliant attempt to unveil key opportunities available in the global Adoptive Cellular Immunotherapy market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

      The Global Adoptive Cellular Immunotherapy Market has been exhibited in detail in the following chapters
      Chapter 1 displays the basic product introduction and market overview.
      Chapter 2 provides the competition landscape of global Adoptive Cellular Immunotherapy industry.
      Chapter 3 provides the market analysis by type and by region
      Chapter 4 provides the market analysis by application and by region
      Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
      Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
      Chapter 12 provides the market forecast by type and by application
      Chapter 13 provides the market forecast by region
      Chapter 14 profies global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
      Chapter 15 conclusions

      Segmented by Type
      TIL
      LAK
      CAR-T
      TCR-T
      CIK
      NK
      DC
      Other

      Segmented by Application
      Hospital
      Cancer Hospital
      Centers for Disease Control and Prevention
      Rehabilitation Center
      Other

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Takara Bio Inc
      Sorrento Therapeutics Inc
      Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
      Ono Pharmaceutical Co Ltd
      Novartis AG
      Nkarta Inc
      NantKwest Inc
      Nanjing Legend Biotech Co Ltd
      Kite Pharma Inc
      Juno Therapeutics Inc
      HRAIN Biotechnology Co Ltd
      Hebei Senlang Biotechnology Inc Ltd
      Hangzhou Converd Co Ltd
      Guangzhou Anjie Biomedical Technology Co Ltd
      Gilead Sciences Inc
      Fosun Pharmaceutical AG
      Daiichi Sankyo Co Ltd
      Celyad SA
      Celularity Inc
      Cellular Biomedicine Group Inc
      Cell Medica Ltd
      Celgene Corp
      CARsgen Therapeutics Ltd
      Bristol-Myers Squibb Co
      bluebird bio Inc
      Bellicum Pharmaceuticals Inc
      Beijing Immunochina Medical Science & Technology Co Ltd
      Autolus Therapeutics Plc
      Amgen Inc


      Summary:
      Get latest Market Research Reports on Adoptive Cellular Immunotherapy. Industry analysis & Market Report on Adoptive Cellular Immunotherapy is a syndicated market report, published as Global Adoptive Cellular Immunotherapy Market Status and Forecast 2021-2027. It is complete Research Study and Industry Analysis of Adoptive Cellular Immunotherapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $2,980.00
      $4,470.00
      $5,960.00
      2,151.56
      3,227.34
      4,303.12
      2,521.08
      3,781.62
      5,042.16
      327,680.80
      491,521.20
      655,361.60
      221,861.00
      332,791.50
      443,722.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report